U.S. Markets close in 4 hrs 34 mins

Inspyr Therapeutics, Inc. (NSPX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0063-0.0003 (-4.55%)
As of 11:11AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) -17.35
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.7470
52 Week Low 30.0005
50-Day Moving Average 30.0179
200-Day Moving Average 30.0129

Share Statistics

Avg Vol (3 month) 320.06M
Avg Vol (10 day) 32.95M
Shares Outstanding 5504.29M
Implied Shares Outstanding 6N/A
Float 389.19M
% Held by Insiders 10.00%
% Held by Institutions 14.97%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 29, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Jun 29, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-149.88%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -476k
Net Income Avi to Common (ttm)-6.36M
Diluted EPS (ttm)-0.1470
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)404k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.88M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.03
Book Value Per Share (mrq)-0.07

Cash Flow Statement

Operating Cash Flow (ttm)-374k
Levered Free Cash Flow (ttm)4.9M